[{"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":169500000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":172500000.0,"RevenuesConverted_1_Q3_USD":1053300000.0,"RevenuesConverted_3_Q3_USD":2809800000.0,"NetIncomeLossConverted_1_Q3_USD":217100000.0,"CommonStockSharesConverted_0_Q3_shares":170133258.0,"Assets_0_Q3_USD":8769100000.0,"StockholdersEquity_0_Q3_USD":3713200000.0,"CommonStockSharesOutstanding_0_Q3_shares":170133258.0,"EarningsPerShareDiluted_3_Q3_USD":2.12,"EarningsPerShareDiluted_1_Q3_USD":1.26,"NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":298700000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":167200000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":170500000.0,"StockholdersEquityConverted_0_Q3_USD":3713200000.0,"NetIncomeLossConverted_3_Q3_USD":402600000.0,"EarningsPerShareBasic_3_Q3_USD":2.15,"EarningsPerShareBasic_1_Q3_USD":1.27,"Ticker":"CTLT","CIK":"1596783","name":"CATALENT, INC.","OfficialName":"Catalent Inc. Common Stock","form":"10-Q","period":"20210331","fy":"2021.0","fp":"Q3","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"17076283108.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"SP500","filed":"20210504"}]